Literature DB >> 24662962

Effects of naproxen on immune responses in a colchicine-induced rat model of Alzheimer's disease.

Susmita Sil1, Ananda Raj Goswami, Goutam Dutta, Tusharkanti Ghosh.   

Abstract

BACKGROUND: The components of the immune system have been indicated to be linked with the neurotoxicity in Alzheimer's disease (AD). The participation of the immune system in the neurodegeneration in a rat model of colchicine-induced AD has not been explored.
METHODS: In the present study, hippocampal neurodegeneration along with reactive oxygen species (ROS), nitrite and TNF-α in the hippocampus and some systemic immune responses were measured after 15 and 21 days of intracerebroventricular colchicine injection in rats and again after oral administration of different doses of the anti-inflammatory drug naproxen in AD rats.
RESULTS: Chromatolysis and amyloid plaques were found along with higher ROS, nitrite and TNF-α levels in the hippocampus of colchicine-induced AD rats, and these changes were prevented by naproxen in a dose-dependent manner. Alterations in immunological parameters [increased phagocytic activity of white blood cells and splenic polymorphonuclear cells (PMN), increased cytotoxicity and decreased leucocyte adhesive inhibition index (LAI) of splenic mononuclear cells (MNC)] were also observed in colchicine-injected rats, which showed a dose-dependent recovery after oral administration of naproxen in AD rats. The number of plaques, chromatolysis of Nissl granules, TNF-α, nitrite and ROS levels in the hippocampus, phagocytic activity of splenic PMN and LAI of splenic MNC in AD rats showed greater changes in the 21- than in the 15-day study, and the recovery of these parameters after administration of naproxen differed between the two study durations.
CONCLUSION: The present study shows that colchicine-induced neurodegeneration is time dependent and mediated by cyclooxygenase-induced neuroinflammation, which is reflected in the systemic immunological responses.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662962     DOI: 10.1159/000357735

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  10 in total

1.  Dual Role of Vitamin C on the Neuroinflammation Mediated Neurodegeneration and Memory Impairments in Colchicine Induced Rat Model of Alzheimer Disease.

Authors:  Susmita Sil; Tusharkanti Ghosh; Pritha Gupta; Rupsa Ghosh; Syed N Kabir; Avishek Roy
Journal:  J Mol Neurosci       Date:  2016-09-24       Impact factor: 3.444

2.  Intracerebroventricular Aβ-Induced Neuroinflammation Alters Peripheral Immune Responses in Rats.

Authors:  Pritha Gupta; Susmita Sil; Rupsa Ghosh; Arijit Ghosh; Tusharkanti Ghosh
Journal:  J Mol Neurosci       Date:  2018-10-31       Impact factor: 3.444

Review 3.  Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside.

Authors:  Awanish Mishra; Ritam Bandopadhyay; Prabhakar Kumar Singh; Pragya Shakti Mishra; Neha Sharma; Navneet Khurana
Journal:  Metab Brain Dis       Date:  2021-08-13       Impact factor: 3.584

Review 4.  Rodent models of neuroinflammation for Alzheimer's disease.

Authors:  Amir Nazem; Roman Sankowski; Michael Bacher; Yousef Al-Abed
Journal:  J Neuroinflammation       Date:  2015-04-17       Impact factor: 8.322

5.  Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention.

Authors:  Cansu Agca; Diana Klakotskaia; Todd R Schachtman; Anthony W Chan; James J Lah; Yuksel Agca
Journal:  BMC Neurosci       Date:  2016-07-07       Impact factor: 3.288

6.  Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer's disease rats.

Authors:  Xu Wang; Guang-Jian Li; Hai-Xia Hu; Chi Ma; Di-Hui Ma; Xiao-Liang Liu; Xiao-Ming Jiang
Journal:  Transl Neurosci       Date:  2016-12-24       Impact factor: 1.757

7.  The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegeneration.

Authors:  Amanda K Engstrom; Alicia C Walker; Rohitha A Moudgal; Dexter A Myrick; Stephanie M Kyle; Yu Bai; M Jordan Rowley; David J Katz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

Review 8.  Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment.

Authors:  Julia Barczuk; Natalia Siwecka; Weronika Lusa; Wioletta Rozpędek-Kamińska; Ewa Kucharska; Ireneusz Majsterek
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

9.  Cox-2 Plays a Vital Role in the Impaired Anxiety Like Behavior in Colchicine Induced Rat Model of Alzheimer Disease.

Authors:  Susmita Sil; Tusharkanti Ghosh
Journal:  Behav Neurol       Date:  2016-01-10       Impact factor: 3.342

10.  The protective effects of naproxen against interleukin-1β (IL-1β)- induced damage in human umbilical vein endothelial cells (HUVECs).

Authors:  Yuliang Wu; Ruina Hao; Beidi Lan; Yiping Mu; Fuping Dang; Ruitao Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.